CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

The role of some drugs, Glycemic control and renal function test in patient with coronary artery calcification

Author: 
Noor N Nafie
Subject Area: 
Health Sciences
Abstract: 

Background: Coronary Computed Tomography Angiography (CCTA) is a rapidly growing, noninvasive imaging modality that developed quickly over the last decade, and its role for evaluation of Coronary Artery Disease (CAD) becomes of great promise with high diagnostic accuracy. The presence and extent of Coronary Artery Calcification (CAC) correlates with the overall magnitude of coronary atherosclerotic plaque burden and with the development of subsequent coronary events. Glycated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also HbA1c or HGBA1C) is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. Glycated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also HbA1c or HGBA1C) is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. This serves as a marker for average blood glucose levels over the previous 3 months prior to the measurement as this is the half life of red blood cells. It represents a reliable and moving average of blood glucose over preceding three months, Glycated haemoglobin has been the key measure of glycaemic control in diabetic patients for last two decades. It is considered to be the gold standard test, and most widely accepted test of glycaemia among clinicians and patients. Subjects and Methods: This study was conducted at the Department of Biochemistry, College of Pharmacy, University of AL-Rasheed and at the Cardiologic Clinics of Ibn-Al-Bitar Hospital, Baghdad, Iraq, during the period from January 2015 to March 2015. The included 40 patients with ischemic heart disease were classified according to their obtained values of coronary artery Ca score into two groups: Group I (GII) involved 20 patients with coronary artery Ca score equal to 1- 399 (ASU), aged mean( 54.95±1.764) with range (37-70 year), Group II (GI) included 20 subjects who have coronary artery Ca score=0.0 Agatston Score Unit (ASU), aged mean (45.80±2.163) range (31-65 year). These subjects were considered as control group. HbA1c, fasting serum glucose, lipid profile parameters and renal function test (Urea, Creatinine & uric Acid) were also measured by using spectrophotometric methods. All investigations were performed in patients of the two groups (GI and GII). Results: The results of this study revealed significant increase in HbA1c significantly increased in GI compared with GII (P=0.019), with significant increased of (Urea, Creatinine & uric Acid) (P=0.001, p=0.004, p= 0.002) between groups. There was no significant differences in glucose & lipid profile between GI and GII in the these parameters. All patients of GII (with Ca Score =zero) taking statin & Aspirin as protective therapy compare to GI (13/20), (7/20) & which represent (65%) (35%) of this group, (p=0.004#, p=0.0001), these drugs play statically a significant role in treatment of Coronary Artery Calcification(CAC). There is non significant correlation between parameters of (lipid profile, glycemic control & renal function test) with ca- score in GI II(patients with mild to moderate degree of calcification). Conclusion: (CAC) consider to be surrogate marker of atherosclerosis which has been associate with increase value of Hb A1c%, serum level of (Urea, Creatinine & uric Acid) in patients with mild to severe degree of calcification ,combine with high serum level of both glucose & VLDL. All these parameters may play important role in pathogenesis of atherosclerosis in patients with CAD, Statin, Aspirin have protective role in patients with CAD while B-blocker to increase of the survival in and improved QoL of these patients with mild to moderate degree of calcification in patients with Ca score =0.0 Agatston.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran